The contemporary social organisation of medical work is characterised by internal hierarchies and stratification in the form of professional elites and managerial hybrids. This paper examines the changes in medical restratification brought about by the introduction of inter-organisational care networks. The study focuses in particular on the social position of doctors and the contingencies that enable or constrain intra-professional hierarchies across inter-organisational boundaries. This ethnographic study of major system change within the English healthcare system finds that a relatively small group of 'multiplex' elites have significant influence in both national policy-making and regional service re-configuration based upon multiple sources of clinical and reputational capital. Subsequent forms of restratification at the regional level are found to mirror such status markers whilst also revealing important local contingencies, especially where professional markers of distinction are coupled with and dependent upon organisational markers of distinction.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.socscimed.2020.113277 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploratory Development of a Prognostic Model for Coronary Artery Disease Utilizing CT-FFR Derived Functional Duke Jeopardy Score.
Acad Radiol
December 2024
Department of Radiology, General Hospital of Ningxia Medical University, Yinchuan 750003, China. Electronic address:
Rationale And Objectives: To explore the prognostic value of the functional Duke Jeopardy Score based on CT-FFR(fDJS) in assessing major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD).
Materials And Methods: A total of 894 patients with stable CAD with stenosis ranging from 30% to 90%, who underwent CCTA were included in the study. Follow-up was performed to record MACE.
Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling.
iScience
September 2024
Discipline of Pharmacology and Therapeutics, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
CMS4 colorectal cancer (CRC), based on the consensus molecular subtype (CMS), stratifies patients with the poorest disease-free survival rates. It is characterized by a strong mesenchymal stromal cell (MSC) signature, wound healing-like inflammation and therapy resistance. We utilized 2D and 3D , and models to assess the impact of inflammation and stromal cells on immunosuppression in CMS4 CRC.
View Article and Find Full Text PDFThe prevalence, patients' characteristics, and hyper-Lp(a)-emia risk factors in the Polish population. The first results from the PMMHRI-Lp(a) Registry.
Prog Cardiovasc Dis
October 2024
Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland; Department of Cardiology and Adult Congenital Heart Diseases, Polish Mother's Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, 65-417 Zielona Gora, Poland. Electronic address:
Article Synopsis
- The study focused on understanding how common high lipoprotein(a) levels are in patients from Poland, especially since there wasn’t much information available before.
- A registry was created at a big hospital in Poland to collect data from patients visiting different medical departments since January 2022.
- Out of 511 patients included, many had elevated Lp(a) levels, and while there were some interesting findings about who had high levels, there weren’t major differences based on sex or many other health conditions.
The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Front Immunol
May 2024
Medical Oncology, Nanjing Jinling Hospital, Nanjing, China.
Background: For decades, stratification criteria for first-line clinical studies have been highly uniform. However, there is no principle or consensus for restratification after systemic treatment progression based on immune checkpoint inhibitors (ICIs). The aim of this study was to assess the patterns of disease progression in patients with advanced hepatocellular carcinoma (HCC) who are not eligible for surgical intervention, following the use of immune checkpoint inhibitors.
View Article and Find Full Text PDFInaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk.
Clin Chem
March 2024
Clinical Chemistry Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Background: Lipid profiling is central for coronary artery disease (CAD) risk assessment. Nonadherence or unreported use of lipid-lowering drugs, particularly statins, can significantly complicate the association between lipid profile measures and CAD clinical outcomes. By combining medication history evaluation with statin analysis in plasma, we determined the effects of inaccurately reported statin use on lipid profile measures and their association with CAD risk.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!